Application 022465
- Type
- NDA
- Sponsor
- NOVARTIS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VOTRIENT | PAZOPANIB HYDROCHLORIDE | TABLET;ORAL | EQ 200MG BASE | Yes | Yes |
| 002 | VOTRIENT | PAZOPANIB HYDROCHLORIDE | TABLET;ORAL | EQ 400MG BASE | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N022465-001 | VOTRIENT | PAZOPANIB HYDROCHLORIDE | EQ 200MG BASE | TABLET / ORAL | AB | RLD, RS | 2009-10-19 |
| N022465-002 | VOTRIENT | PAZOPANIB HYDROCHLORIDE | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2009-10-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N022465-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N022465-001 | VOTRIENT | EQ 200MG BASE | TABLET / ORAL | AB | RLD, RS | 2009-10-19 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N022465-002 | VOTRIENT | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2009-10-19 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022465-001 | VOTRIENT | EQ 200MG BASE | TABLET / ORAL | AB | RLD, RS | 2009-10-19 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N022465-002 | VOTRIENT | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2009-10-19 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022465-001 | VOTRIENT | EQ 200MG BASE | TABLET / ORAL | AB | RLD, RS | 2009-10-19 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022465-002 | VOTRIENT | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2009-10-19 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022465-001 | VOTRIENT | EQ 200MG BASE | TABLET / ORAL | AB | RLD, RS | 2009-10-19 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N022465-002 | VOTRIENT | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2009-10-19 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022465-001 | VOTRIENT | EQ 200MG BASE | TABLET / ORAL | AB | RLD, RS | 2009-10-19 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022465-002 | VOTRIENT | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2009-10-19 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022465-001 | VOTRIENT | EQ 200MG BASE | TABLET / ORAL | AB | RLD, RS | 2009-10-19 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022465-002 | VOTRIENT | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2009-10-19 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022465-001 | VOTRIENT | EQ 200MG BASE | TABLET / ORAL | AB | RLD, RS | 2009-10-19 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022465-002 | VOTRIENT | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2009-10-19 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022465-001 | VOTRIENT | EQ 200MG BASE | TABLET / ORAL | AB | RLD, RS | 2009-10-19 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022465-002 | VOTRIENT | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2009-10-19 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022465-001 | VOTRIENT | EQ 200MG BASE | TABLET / ORAL | AB | RLD, RS | 2009-10-19 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022465-002 | VOTRIENT | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2009-10-19 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022465-001 | VOTRIENT | EQ 200MG BASE | TABLET / ORAL | AB | RLD, RS | 2009-10-19 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022465-002 | VOTRIENT | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2009-10-19 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N022465-001 | VOTRIENT | EQ 200MG BASE | TABLET / ORAL | AB | RLD, RS | 2009-10-19 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N022465-002 | VOTRIENT | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2009-10-19 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022465-001 | VOTRIENT | EQ 200MG BASE | TABLET / ORAL | AB | RLD, RS | 2009-10-19 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022465-002 | VOTRIENT | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2009-10-19 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022465-001 | VOTRIENT | EQ 200MG BASE | TABLET / ORAL | AB | RLD, RS | 2009-10-19 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022465-002 | VOTRIENT | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2009-10-19 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022465-001 | VOTRIENT | EQ 200MG BASE | TABLET / ORAL | AB | RLD, RS | 2009-10-19 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022465-002 | VOTRIENT | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2009-10-19 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N022465-001 | VOTRIENT | EQ 200MG BASE | TABLET / ORAL | AB | RLD, RS | 2009-10-19 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | N022465-002 | VOTRIENT | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2009-10-19 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022465-001 | VOTRIENT | EQ 200MG BASE | TABLET / ORAL | RLD, RS | 2009-10-19 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022465-002 | VOTRIENT | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2009-10-19 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N022465-001 | VOTRIENT | EQ 200MG BASE | TABLET / ORAL | RLD, RS | 2009-10-19 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N022465-002 | VOTRIENT | EQ 400MG BASE | TABLET / ORAL | RLD | 2009-10-19 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N022465-001 | VOTRIENT | EQ 200MG BASE | TABLET / ORAL | RLD, RS | 2009-10-19 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N022465-002 | VOTRIENT | EQ 400MG BASE | TABLET / ORAL | RLD | 2009-10-19 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022465-001 | VOTRIENT | EQ 200MG BASE | TABLET / ORAL | RLD, RS | 2009-10-19 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022465-002 | VOTRIENT | EQ 400MG BASE | TABLET / ORAL | 2009-10-19 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N022465-001 | VOTRIENT | EQ 200MG BASE | TABLET / ORAL | RLD, RS | 2009-10-19 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N022465-002 | VOTRIENT | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2009-10-19 | bb7c543d1eb4… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N022465-001 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N022465-001 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022465-001 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N022465-001 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022465-001 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022465-001 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022465-001 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022465-001 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022465-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022465-001 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N022465-001 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022465-001 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022465-001 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022465-001 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N022465-001 | AB | 1 | 8072bd15b7f6… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N022465-001 | AB | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | N022465-001 | AB | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | N022465-001 | AB | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N022465-001 | AB | 1 | a72a2bbeb626… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N022465-001 | AB | 1 | a50c72e98297… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022465-001 | 7105530 | 2023-10-19 | Drug substance, Drug product | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022465-002 | 7105530 | 2023-10-19 | Drug substance, Drug product | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N022465-001 | 7105530 | 2023-10-19 | Drug substance, Drug product | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N022465-002 | 7105530 | 2023-10-19 | Drug substance, Drug product | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N022465-001 | 7105530 | 2023-10-19 | Drug substance, Drug product | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N022465-002 | 7105530 | 2023-10-19 | Drug substance, Drug product | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N022465-001 | 7262203 | 2021-12-19 | Drug substance, Drug product | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N022465-001 | 8114885 | 2021-12-19 | Drug substance, Drug product | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N022465-001 | 7105530 | 2023-10-19 | Drug substance, Drug product | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N022465-002 | 7262203 | 2021-12-19 | Drug substance, Drug product | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N022465-002 | 8114885 | 2021-12-19 | Drug substance, Drug product | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N022465-002 | 7105530 | 2023-10-19 | Drug substance, Drug product | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N022465-001 | 7105530 | 2023-10-19 | Drug substance, Drug product | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N022465-002 | 7105530 | 2023-10-19 | Drug substance, Drug product | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N022465-001 | 7262203 | 2021-12-19 | Drug substance, Drug product | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N022465-001 | 8114885 | 2021-12-19 | Drug substance, Drug product | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N022465-001 | 7105530 | 2023-10-19 | Drug substance, Drug product | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N022465-002 | 7262203 | 2021-12-19 | Drug substance, Drug product | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N022465-002 | 8114885 | 2021-12-19 | Drug substance, Drug product | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N022465-002 | 7105530 | 2023-10-19 | Drug substance, Drug product | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022465-001 | 7262203 | 2021-12-19 | Drug substance, Drug product | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022465-001 | 8114885 | 2021-12-19 | Drug substance, Drug product | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022465-001 | 7105530 | 2023-10-19 | Drug substance, Drug product | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022465-002 | 7262203 | 2021-12-19 | Drug substance, Drug product | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022465-002 | 8114885 | 2021-12-19 | Drug substance, Drug product | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022465-002 | 7105530 | 2023-10-19 | Drug substance, Drug product | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N022465-001 | 7262203 | 2021-12-19 | Drug substance, Drug product | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N022465-001 | 8114885 | 2021-12-19 | Drug substance, Drug product | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N022465-001 | 7105530 | 2023-10-19 | Drug substance, Drug product | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N022465-002 | 7262203 | 2021-12-19 | Drug substance, Drug product | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N022465-002 | 8114885 | 2021-12-19 | Drug substance, Drug product | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N022465-002 | 7105530 | 2023-10-19 | Drug substance, Drug product | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N022465-001 | 7262203 | 2021-12-19 | Drug substance, Drug product | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N022465-001 | 8114885 | 2021-12-19 | Drug substance, Drug product | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N022465-001 | 7105530 | 2023-10-19 | Drug substance, Drug product | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N022465-002 | 7262203 | 2021-12-19 | Drug substance, Drug product | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N022465-002 | 8114885 | 2021-12-19 | Drug substance, Drug product | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N022465-002 | 7105530 | 2023-10-19 | Drug substance, Drug product | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N022465-001 | 7262203 | 2021-12-19 | Drug substance, Drug product | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N022465-001 | 8114885 | 2021-12-19 | Drug substance, Drug product | c0c555d07b60… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N022465-001 | ODE-23 | 2019-04-26 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N022465-002 | ODE-23 | 2019-04-26 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | N022465-001 | ODE-23 | 2019-04-26 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N022465-002 | ODE-23 | 2019-04-26 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N022465-001 | ODE-23 | 2019-04-26 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N022465-002 | ODE-23 | 2019-04-26 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N022465-001 | ODE-23 | 2019-04-26 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N022465-002 | ODE-23 | 2019-04-26 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VOTRIENT | PAZOPANIB HYDROCHLORIDE | Novartis Pharmaceuticals Corporation | eeaaaf38-fb86-4d9f-a19d-0f61daac2fd7 | 2025-12-16 | Boxed warning, Warnings, Adverse reactions | 022465 NDA022465 0078-1077 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0078-0670 | VOTRIENT | pazopanib hydrochloride | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0670 | VOTRIENT | pazopanib hydrochloride | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0670 | VOTRIENT | pazopanib hydrochloride | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0670 | VOTRIENT | pazopanib hydrochloride | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0670 | VOTRIENT | pazopanib hydrochloride | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0670 | VOTRIENT | pazopanib hydrochloride | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0670 | VOTRIENT | pazopanib hydrochloride | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0670 | VOTRIENT | pazopanib hydrochloride | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-1077 | VOTRIENT | pazopanib hydrochloride | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-1077 | VOTRIENT | pazopanib hydrochloride | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-1077 | VOTRIENT | pazopanib hydrochloride | Novartis Pharmaceuticals Corporation | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 77316 | SUPPL | 2024-01-26 |
| 77313 | SUPPL | 2024-01-26 |
| 77312 | SUPPL | 2024-01-26 |
| 70233 | SUPPL | 2022-02-23 |
| 70185 | SUPPL | 2022-02-18 |
| 68816 | SUPPL | 2021-09-30 |
| 68815 | SUPPL | 2021-09-30 |
| 68814 | SUPPL | 2021-09-30 |
| 68733 | SUPPL | 2021-09-23 |
| 68732 | SUPPL | 2021-09-23 |
| 64294 | SUPPL | 2020-08-18 |
| 64293 | SUPPL | 2020-08-18 |
| 64292 | SUPPL | 2020-08-18 |
| 64058 | SUPPL | 2020-07-23 |
| 64057 | SUPPL | 2020-07-23 |
| 63974 | SUPPL | 2020-07-20 |
| 63467 | SUPPL | 2020-06-09 |
| 63466 | SUPPL | 2020-06-09 |
| 63408 | SUPPL | 2020-06-03 |
| 48646 | SUPPL | 2017-06-05 |
| 48645 | SUPPL | 2017-06-05 |
| 48623 | SUPPL | 2017-06-01 |
| 48622 | SUPPL | 2017-06-01 |
| 48621 | SUPPL | 2017-06-01 |
| 48620 | SUPPL | 2017-06-01 |
| 45038 | SUPPL | 2016-08-05 |
| 45002 | SUPPL | 2016-08-05 |
| 29757 | SUPPL | 2016-05-24 |
| 17615 | SUPPL | 2016-05-23 |
| 17614 | SUPPL | 2015-10-06 |
| 29756 | SUPPL | 2015-09-24 |
| 38741 | SUPPL | 2015-04-02 |
| 7431 | SUPPL | 2015-04-02 |
| 17613 | SUPPL | 2015-04-01 |
| 17612 | SUPPL | 2014-11-20 |
| 7430 | SUPPL | 2014-11-20 |
| 29755 | SUPPL | 2014-06-05 |
| 38740 | SUPPL | 2014-06-04 |
| 7429 | SUPPL | 2013-12-18 |
| 38739 | SUPPL | 2013-12-03 |
| 29754 | SUPPL | 2013-08-16 |
| 29753 | SUPPL | 2013-08-16 |
| 7428 | SUPPL | 2013-08-16 |
| 38738 | SUPPL | 2013-08-15 |
| 17611 | SUPPL | 2013-08-15 |
| 17610 | SUPPL | 2013-08-15 |
| 38737 | SUPPL | 2012-11-16 |
| 7427 | SUPPL | 2012-11-16 |
| 29752 | SUPPL | 2012-05-02 |
| 7425 | SUPPL | 2012-05-02 |
| 17609 | SUPPL | 2012-04-27 |
| 17607 | SUPPL | 2012-04-27 |
| 7426 | SUPPL | 2012-03-26 |
| 17608 | SUPPL | 2012-03-23 |
| 38736 | SUPPL | 2012-01-23 |
| 7424 | SUPPL | 2012-01-17 |
| 38735 | SUPPL | 2011-10-25 |
| 17606 | SUPPL | 2011-10-25 |
| 7422 | SUPPL | 2011-10-25 |
| 7421 | SUPPL | 2011-10-25 |
| 7423 | SUPPL | 2011-04-22 |
| 38734 | SUPPL | 2010-05-07 |
| 7420 | SUPPL | 2010-05-03 |
| 24315 | ORIG | 2010-01-22 |
| 22028 | ORIG | 2010-01-22 |
| 7419 | ORIG | 2009-11-03 |
| 17605 | ORIG | 2009-10-20 |